Cargando…

Neurofibromatosis Type 1–Associated MPNST State of the Science: Outlining a Research Agenda for the Future

Malignant peripheral nerve sheath tumor (MPNST) is an aggressive soft tissue sarcoma for which the only effective therapy is surgery. In 2016, an international meeting entitled “MPNST State of the Science: Outlining a Research Agenda for the Future” was convened to establish short- and long-term res...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reilly, Karlyne M., Kim, AeRang, Blakely, Jaishri, Ferner, Rosalie E., Gutmann, David H., Legius, Eric, Miettinen, Markku M., Randall, R. Lor, Ratner, Nancy, Jumbé, N. L., Bakker, Annette, Viskochil, David, Widemann, Brigitte C., Stewart, Douglas R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057517/ https://www.ncbi.nlm.nih.gov/pubmed/29117388 http://dx.doi.org/10.1093/jnci/djx124

Ejemplares similares

Malignant Peripheral Nerve Sheath Tumors State of the Science: Leveraging Clinical and Biological Insights into Effective Therapies
por: Kim, AeRang, et al.
Publicado: (2017)

NFB-01. FUNCTIONAL CHARACTERIZATION OF ATRX LOSS IN NF1-ASSOCIATED GLIOMA AND MPNST
por: Yuan, Ming, et al.
Publicado: (2020)

Targeting Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors (MPNST) in a Phase II Study of Everolimus in Combination with Bevacizumab (SARC016)
por: Widemann, Brigitte C., et al.
Publicado: (2019)

Neurofibromatosis and lessons for the war on cancer
por: Reilly, Karlyne M
Publicado: (2009)

Identifying challenges in neurofibromatosis: a modified Delphi procedure
por: Dhaenens, Britt A. E., et al.
Publicado: (2021)

Monozygotic twins with Neurofibromatosis type 1, concordant phenotype and synchronous development of MPNST and metastasis
por: Melean, German, et al.
Publicado: (2010)

Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
por: Legius, Eric, et al.
Publicado: (2021)

Case report of adrenocortical carcinoma associated with double germline mutations in MSH2 and RET
por: Raygada, Margarita, et al.
Publicado: (2021)

Metastatic Malignant Peripheral Nerve Sheath Tumor (MPNST) in Neurofibromatosis Type 1: Challenges in Diagnosis and Management
por: Pulliam, Steven, et al.
Publicado: (2022)

Plexiform neurofibroma of the liver, with malignant transformation to MPNST, in a pediatric patient without neurofibromatosis type 1
por: Ioannou, Maria, et al.
Publicado: (2023)

CK2 blockade causes MPNST cell apoptosis and promotes degradation of β-catenin
por: Kendall, Jed J., et al.
Publicado: (2016)

ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1
por: Carton, Charlotte, et al.
Publicado: (2023)

Conditional Inactivation of Pten with EGFR Overexpression in Schwann Cells Models Sporadic MPNST
por: Keng, Vincent W., et al.
Publicado: (2012)

Whole Body MRI at 3T with Quantitative Diffusion Weighted Imaging and Contrast-Enhanced Sequences for the Characterization of Peripheral Lesions in Patients with Neurofibromatosis Type 2 and Schwannomatosis
por: Fayad, Laura M., et al.
Publicado: (2013)

Characterization and utilization of an international neurofibromatosis web-based, patient–entered registry: An observational study
por: Seidlin, Mindell, et al.
Publicado: (2017)

Reliability of functional outcome measures in adults with neurofibromatosis 1
por: Mullin, Rebecca L, et al.
Publicado: (2018)

BCRP expression in schwannoma, plexiform neurofibroma and MPNST
por: de Vries, Maurits, et al.
Publicado: (2017)

Legius Syndrome and its Relationship with Neurofibromatosis Type 1
por: DENAYER, Ellen, et al.
Publicado: (2020)

How Effective Are Noninvasive Tests for Diagnosing Malignant Peripheral Nerve Sheath Tumors in Patients with Neurofibromatosis Type 1? Diagnosing MPNST in NF1 Patients
por: Schwabe, Maria, et al.
Publicado: (2019)

Abdominal neoplastic manifestations of neurofibromatosis type 1
por: Dare, Anna J, et al.
Publicado: (2020)

Feasibility of magnetic resonance-guided high-intensity focused ultrasound treatment targeting distinct nodular lesions in neurofibromatosis type 1
por: Tydings, Caitlin, et al.
Publicado: (2021)

Brain tumors in neurofibromatosis type 1
por: Costa, Amanda De Andrade, et al.
Publicado: (2019)

Factors Within the Endoneurial Microenvironment Act to Suppress Tumorigenesis of MPNST
por: Stratton, Jo Anne, et al.
Publicado: (2018)

Chromosome 8 gain is associated with high-grade transformation in MPNST
por: Dehner, Carina, et al.
Publicado: (2021)

Malignant transformation of plexiform neurofibroma to MPNST while on MEK inhibitor
por: Fasih, Samir, et al.
Publicado: (2021)

PRC2 loss drives MPNST metastasis and matrix remodeling
por: Brockman, Qierra R., et al.
Publicado: (2022)

SHH PATHWAY ACTIVATION IN DEDIFFERENTIATION DURING TUMOR PROGRESSION IN MPNST
por: Yakubov, R Y, et al.
Publicado: (2023)

Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas
por: Byrne, Susan, et al.
Publicado: (2017)

Characterisation of malignant peripheral nerve sheath tumours in neurofibromatosis-1 using heterogeneity analysis of (18)F-FDG PET
por: Cook, Gary J. R., et al.
Publicado: (2017)

COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis
por: Banerjee, Jineta, et al.
Publicado: (2023)

Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA
por: Cortes-Ciriano, Isidro, et al.
Publicado: (2023)

Unmasking Intra-Tumoral Heterogeneity and Clonal Evolution in NF1-MPNST
por: Moon, Chang-In, et al.
Publicado: (2020)

Oncogenic RABL6A promotes NF1-associated MPNST progression in vivo
por: Kohlmeyer, Jordan L, et al.
Publicado: (2022)

Genetically engineered minipigs model the major clinical features of human neurofibromatosis type 1
por: Isakson, Sara H., et al.
Publicado: (2018)

Putting a stop to nonsense: Revisiting gene correction therapy for neurofibromatosis type 1
por: Gutmann, David H.
Publicado: (2023)

The effect of post-injection (18)F-FDG PET scanning time on texture analysis of peripheral nerve sheath tumours in neurofibromatosis-1
por: Lovat, Eitan, et al.
Publicado: (2017)

RAS and beyond: the many faces of the neurofibromatosis type 1 protein
por: Anastasaki, Corina, et al.
Publicado: (2022)

Using the Neurofibromatosis Tumor Predisposition Syndromes to Understand Normal Nervous System Development
por: Garcia, Cynthia, et al.
Publicado: (2014)

Succinate Dehydrogenase Subunit B (SDHB) Is Expressed in Neurofibromatosis 1-Associated Gastrointestinal Stromal Tumors (Gists): Implications for the SDHB Expression Based Classification of Gists
por: Wang, Jeanny H., et al.
Publicado: (2011)

Funding community collaboration to develop effective therapies for neurofibromatosis type 1 tumors
por: La Rosa, Salvatore, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_f6eildqgpr62uni5mpfurf0pqk